Top Wall Street Forecasters Revamp Zoetis Expectations Ahead Of Q4 Earnings

Benzinga02-12

Zoetis Inc. (NYSE:ZTS) will release earnings for its fourth quarter before the opening bell on Thursday, Feb. 12.

Analysts expect the Parsippany, New Jersey-based company to report quarterly earnings at $1.4 per share, compared to $1.4 per share in the year-ago period. The consensus estimate for Zoetis quarterly revenue is $2.36 billion (it reported $2.32 billion last year), according to Benzinga Pro.

On Dec. 16, Zoetis announced pricing of $1.75 billion convertible senior notes offering.

Shares of Zoetis rose 0.4% to close at $128.67 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • Piper Sandler analyst David Westenberg downgraded the stock from Overweight to Neutral and cut the price target from $190 to $135 on Jan. 22, 2026. This analyst has an accuracy rate of 74%.
  • Barclays analyst Glen Santangelo initiated coverage on the stock with an Equal-Weight rating and a price target of $136 on Dec. 9, 2025. This analyst has an accuracy rate of 54%.
  • BTIG analyst Mark Massaro maintained a Buy rating with a price target of $160 on Dec. 3, 2025. This analyst has an accuracy rate of 71%.
  • Keybanc analyst Steve Dechert initiated coverage on the stock with a Sector Weight rating on Nov. 21, 2025. This analyst has an accuracy rate of 58%.
  • Stifel analyst Jonathan Block maintained a Hold rating and slashed the price target from $140 to $130 on Nov. 18, 2025. This analyst has an accuracy rate of 71%

Considering buying ZTS stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment